{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:32:53Z","timestamp":1794857573117,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-06937-3","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T11:31:31Z","timestamp":1752233491000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Construction of a macrophage-related prognostic signature and assessment of immune checkpoint inhibitor efficacy of HCC"],"prefix":"10.1038","volume":"15","author":[{"given":"Shouge","family":"Zang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqian","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangtao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"key":"6937_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"Y Ju Dong","year":"2019","unstructured":"Ju Dong, Y. et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat. Rev. Gastroenterol. Hepatol. 16, 589\u2013604 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"6937_CR2","first-page":"151","volume":"19","author":"ML Josep","year":"2021","unstructured":"Josep, M. L. et al. Immunotherapies for hepatocellular carcinoma. Nat. Rev. Clin. Oncol. 19, 151\u2013172 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"6937_CR3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41575-021-00438-0","volume":"18","author":"S Bruno","year":"2021","unstructured":"Bruno, S. et al. Advances in immunotherapy for hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 18, 525\u2013543 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"6937_CR4","first-page":"203","volume":"20","author":"Y Chen","year":"2022","unstructured":"Chen, Y. et al. Evolving therapeutic landscape of advanced hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 20, 203\u2013222 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"6937_CR5","doi-asserted-by":"crossref","unstructured":"Shuyan, L. et al. Genetic variants of m(6)A modification genes are associated with survival of HBV-related hepatocellular carcinoma. J. Cell. Mol. Med. 28, e18517 (2024).","DOI":"10.1111\/jcmm.18517"},{"key":"6937_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","volume":"30","author":"V Ilio","year":"2019","unstructured":"Ilio, V. et al. Macrophages and metabolism in the tumor microenvironment. Cell. Metab. 30, 36\u201350 (2019).","journal-title":"Cell. Metab."},{"key":"6937_CR7","doi-asserted-by":"publisher","first-page":"3686","DOI":"10.1016\/j.cell.2023.07.026","volume":"186","author":"R Benjamin","year":"2023","unstructured":"Benjamin, R. et al. Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin. Cell 186, 3686\u20133705 (2023).","journal-title":"Cell"},{"key":"6937_CR8","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","volume":"23","author":"C Anthos","year":"2022","unstructured":"Anthos, C. et al. The complex role of tumor-infiltrating macrophages. Nat. Immunol. 23, 1148\u20131156 (2022).","journal-title":"Nat. Immunol."},{"key":"6937_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41568-022-00547-1","volume":"23","author":"C Luca","year":"2023","unstructured":"Luca, C. et al. A timeline of tumour-associated macrophage biology. Nat. Rev. Cancer. 23, 238\u2013257 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"6937_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12943-024-02062-3","volume":"23","author":"G De-Zhen","year":"2024","unstructured":"De-Zhen, G. et al. Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: unraveling the pro-metastatic subtype and its interaction loop with fibroblasts. Mol. Cancer. 23, 157 (2024).","journal-title":"Mol. Cancer"},{"key":"6937_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.molimm.2024.07.015","volume":"174","author":"Y Qiyi","year":"2024","unstructured":"Qiyi, Y. et al. Identification and analysis of significant genes in nonalcoholic steatohepatitis-hepatocellular carcinoma transformation: bioinformatics analysis and machine learning approach. Mol. Immunol. 174, 18\u201331 (2024).","journal-title":"Mol. Immunol."},{"key":"6937_CR12","doi-asserted-by":"crossref","unstructured":"Yonglin, H. et al. Pretreatment CT-based machine learning radiomics model predicts response in unresectable hepatocellular carcinoma treated with lenvatinib plus PD-1 inhibitors and interventional therapy. J. Immunother. Cancer. 12, e008953 (2024).","DOI":"10.1136\/jitc-2024-008953"},{"key":"6937_CR13","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1158\/0008-5472.CAN-24-0943","volume":"84","author":"Z Shuming","year":"2024","unstructured":"Shuming, Z. et al. Integration of clinical trial spatial multiomics analysis and virtual clinical trials enables immunotherapy response prediction and biomarker discovery. Cancer Res. 84, 2734\u20132748 (2024).","journal-title":"Cancer Res."},{"key":"6937_CR14","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1038\/s41467-022-32283-3","volume":"13","author":"L Yiming","year":"2022","unstructured":"Yiming, L. et al. A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma. Nat. Commun. 13, 4594 (2022).","journal-title":"Nat. Commun."},{"key":"6937_CR15","first-page":"D721","volume":"47","author":"Z Xinxin","year":"2018","unstructured":"Xinxin, Z. et al. CellMarker: a manually curated resource of cell markers in human and mouse. Nucleic Acids Res. 47, D721\u2013D728 (2018).","journal-title":"Nucleic Acids Res."},{"key":"6937_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"B Andrew","year":"2018","unstructured":"Andrew, B. et al. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."},{"key":"6937_CR17","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1002\/cam4.4625","volume":"11","author":"S Wentai","year":"2022","unstructured":"Wentai, S. et al. Conditional survival of trimodal therapy for nonmetastatic muscle-invasive bladder cancer: A SEER database analysis. Cancer Med. 11, 2356\u20132365 (2022).","journal-title":"Cancer Med."},{"key":"6937_CR18","doi-asserted-by":"crossref","unstructured":"Yan, Z. et al. Global characterization of immune infiltration in clear cell renal cell carcinoma. Onco Targets Ther. 14. (2021).","DOI":"10.2147\/OTT.S282763"},{"key":"6937_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12943-023-01752-8","volume":"22","author":"Q Yan","year":"2023","unstructured":"Yan, Q. et al. Cuproptosis correlates with immunosuppressive tumor microenvironment based on pan-cancer multiomics and single-cell sequencing analysis. Mol. Cancer. 22, 59 (2023).","journal-title":"Mol. Cancer"},{"key":"6937_CR20","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"J Suoqin","year":"2021","unstructured":"Suoqin, J. et al. Inference and analysis of cell-cell communication using cellchat. Nat. Commun. 12, 1088 (2021).","journal-title":"Nat. Commun."},{"key":"6937_CR21","doi-asserted-by":"crossref","unstructured":"Masahiro, H. et al. Spatial and single-cell colocalisation analysis reveals MDK-mediated immunosuppressive environment with regulatory T cells in colorectal carcinogenesis. EBioMedicine. 103 (2024).","DOI":"10.1016\/j.ebiom.2024.105102"},{"key":"6937_CR22","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.jhep.2021.06.023","volume":"75","author":"Z Yijian","year":"2021","unstructured":"Yijian, Z. et al. Single-cell RNA-sequencing atlas reveals an MDK-dependent immunosuppressive environment in erbb pathway-mutated gallbladder cancer. J. Hepatol. 75, 1128\u20131141 (2021).","journal-title":"J. Hepatol."},{"key":"6937_CR23","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41584-019-0238-2","volume":"15","author":"K Insoo","year":"2019","unstructured":"Insoo, K. et al. The immunobiology of MIF: function, genetics and prospects for precision medicine. Nat. Rev. Rheumatol. 15, 427\u2013437 (2019).","journal-title":"Nat. Rev. Rheumatol."},{"key":"6937_CR24","first-page":"108024","volume":"233","author":"S Krishnamoorthi","year":"2021","unstructured":"Krishnamoorthi, S. et al. Macrophage migration inhibitory factor (MIF): A multifaceted cytokine regulated by genetic and physiological strategies. Pharmacol. Ther. 233, 108024 (2021).","journal-title":"Pharmacol. Ther."},{"key":"6937_CR25","first-page":"15","volume":"58","author":"TB Marcelo","year":"2019","unstructured":"Marcelo, T. B. et al. The role of MIF on eosinophil biology and eosinophilic inflammation. Clin. Rev. Allergy Immunol. 58, 15\u201324 (2019).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"6937_CR26","doi-asserted-by":"publisher","first-page":"7466","DOI":"10.1038\/s41467-022-35130-7","volume":"13","author":"Z Junmeng","year":"2022","unstructured":"Junmeng, Z. et al. Engineered Lactococcus lactis secreting Flt3L and OX40 ligand for in situ vaccination-based cancer immunotherapy. Nat. Commun. 13, 7466 (2022).","journal-title":"Nat. Commun."},{"key":"6937_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-020-01284-5","volume":"20","author":"C Zhixiong","year":"2021","unstructured":"Zhixiong, C. et al. Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion. Mol. Cancer. 20, 1\u201313 (2021).","journal-title":"Mol. Cancer"},{"key":"6937_CR28","doi-asserted-by":"publisher","first-page":"eadg2697","DOI":"10.1126\/sciadv.adg2697","volume":"9","author":"H Shulan","year":"2023","unstructured":"Shulan, H. et al. d-lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma. Sci. Adv. 9, eadg2697 (2023).","journal-title":"Sci. Adv."},{"key":"6937_CR29","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.immuni.2022.01.006","volume":"55","author":"H Kebria","year":"2022","unstructured":"Kebria, H. et al. Tryptophan-derived microbial metabolites activate the Aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity. Immunity 55, 324\u2013340 (2022).","journal-title":"Immunity"},{"key":"6937_CR30","first-page":"75","volume":"19","author":"GDO Filippo","year":"2021","unstructured":"Filippo, G. D. O. et al. Tumour burden and efficacy of immune-checkpoint inhibitors. Nat. Rev. Clin. Oncol. 19, 75\u201390 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"6937_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2022.12.003","volume":"56","author":"Z Xian","year":"2023","unstructured":"Xian, Z. et al. Control of tumor-associated macrophage responses by nutrient acquisition and metabolism. Immunity 56, 14\u201331 (2023).","journal-title":"Immunity"},{"key":"6937_CR32","doi-asserted-by":"publisher","first-page":"121137","DOI":"10.1016\/j.biomaterials.2021.121137","volume":"278","author":"G Gowri Rangaswamy","year":"2021","unstructured":"Gowri Rangaswamy, G. et al. M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages. Biomaterials 278, 121137 (2021).","journal-title":"Biomaterials"},{"key":"6937_CR33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","volume":"6","author":"X Xiaonan","year":"2021","unstructured":"Xiaonan, X. et al. Targeting tumor-associated macrophages to synergize tumor immunotherapy. Signal. Transduct. Target. Ther. 6, 75 (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"6937_CR34","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.7150\/ijbs.69933","volume":"18","author":"Z Tao","year":"2022","unstructured":"Tao, Z. et al. TCF7L2 promotes Anoikis resistance and metastasis of gastric cancer by transcriptionally activating PLAUR. Int. J. Biol. Sci. 18, 4560 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"6937_CR35","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10142-023-01193-y","volume":"23","author":"Z Chao","year":"2023","unstructured":"Chao, Z. et al. YY1 regulates the proliferation and invasion of triple-negative breast cancer via activating PLAUR. Funct. Integr. Genomics. 23, 269 (2023).","journal-title":"Funct. Integr. Genomics"},{"key":"6937_CR36","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3390\/cancers16040840","volume":"16","author":"F Zaixiang","year":"2024","unstructured":"Zaixiang, F. et al. Identifying PLAUR as a pivotal gene of tumor microenvironment and regulating mesenchymal phenotype of glioblastoma. Cancers (Basel). 16, 840 (2024).","journal-title":"Cancers (Basel)"},{"issue":"1","key":"6937_CR37","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1186\/s12951-024-02888-5","volume":"22","author":"Z Xue","year":"2024","unstructured":"Xue, Z. et al. Hypoxic glioma-derived exosomal miR-25-3p promotes macrophage M2 polarization by activating the PI3K-AKT-mTOR signaling pathway. J. Nanobiotechnol. 22 (1), 628 (2024).","journal-title":"J. Nanobiotechnol."},{"issue":"8","key":"6937_CR38","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.7150\/thno.53749","volume":"11","author":"A Zhang","year":"2021","unstructured":"Zhang, A. et al. Lactate-induced M2 polarization of tumor-associated macrophages promotes the invasion of pituitary adenoma by secreting CCL17. Theranostics 11(8), 3839\u20133852 (2021).","journal-title":"Theranostics"},{"key":"6937_CR39","doi-asserted-by":"publisher","first-page":"1436131","DOI":"10.3389\/fimmu.2024.1436131","volume":"15","author":"H Huang","year":"2024","unstructured":"Huang, H. et al. Multi-transcriptomics analysis of microvascular invasion-related malignant cells and development of a machine learning-based prognostic model in hepatocellular carcinoma. Front. Immunol. 15, 1436131 (2024).","journal-title":"Front. Immunol."},{"issue":"27","key":"6937_CR40","doi-asserted-by":"publisher","first-page":"6383","DOI":"10.12998\/wjcc.v11.i27.6383","volume":"11","author":"GX Zhang","year":"2023","unstructured":"Zhang, G. X., Ding, X. S. & Wang, Y. L. Prognostic model of hepatocellular carcinoma based on cancer grade. World J. Clin. Cases. 11(27), 6383\u20136397 (2023).","journal-title":"World J. Clin. Cases"},{"key":"6937_CR41","doi-asserted-by":"publisher","first-page":"857","DOI":"10.2147\/JHC.S453080","volume":"11","author":"H Chen","year":"2024","unstructured":"Chen, H., Li, J., Cao, D. & Tang, H. Construction of a prognostic model for hepatocellular carcinoma based on macrophage polarization-related genes. J. Hepatocell Carcinoma. 11, 857\u2013878 (2024).","journal-title":"J. Hepatocell Carcinoma"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06937-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06937-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06937-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T05:17:02Z","timestamp":1757222222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06937-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6937"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-06937-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]},"assertion":[{"value":"27 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was approved by the Institutional Ethics Committee of Fuyang People\u2019s Hospital of Anhui Medical University. The study was conducted in accordance with the local legislation and institutional requirements. No human studies are presented in the manuscript. No potentially identifiable images or data are presented in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25065"}}